# Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.

> **NCT05432115** · PHASE4 · UNKNOWN · sponsor: **Shandong University** · enrollment: 407 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Tetracyclin

## Key facts

- **NCT ID:** NCT05432115
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-25
- **Primary completion:** 2023-08
- **Final completion:** 2023-10
- **Target enrollment:** 407 (ESTIMATED)
- **Last updated:** 2023-01-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05432115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05432115, "Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05432115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*